[1]
Lipika Ghosh et al. 2022. A comparative prospective observational study on the use of ulipristal acetate versus mifepristone in reduction of the size of uterine leiomyoma. Asian Journal of Medical Sciences. 13, 1 (Jan. 2022), 129–135.